BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that Clay B. Siegall, Ph.D., President and Chief Executive Officer, will present in two sessions during the Biotechnology Industry Organization (BIO) Investor Forum taking place at the Palace Hotel in San Francisco. Dr. Siegall will provide a company update on Wednesday, October 18, at 10:40 a.m. Pacific Time. The presentation will be webcast live and available for replay from the Seattle Genetics website, www.seattlegenetics.com, under the "news and investor information" section.
